{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:58:26Z","timestamp":1793750306842,"version":"4.6.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.07.022","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T09:32:51Z","timestamp":1437211971000},"page":"4406-4413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)\u2014Structure, function and species differences"],"prefix":"10.1016","volume":"33","author":[{"given":"Reinhard","family":"Pabst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.022_bib0395","series-title":"Principles of mucosal immunology","first-page":"413","article-title":"Principles of mucosal vaccine strategies","author":"Holmgren","year":"2013"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0400","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/erv.11.196","article-title":"Novel vaccine development strategies for inducing mucosal immunity","volume":"11","author":"Fukuyama","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0405","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0410","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0415","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.it.2004.09.005","article-title":"Let's go mucosal: communication on slippery ground","volume":"25","author":"Brandtzaeg","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mi.2007.9","article-title":"Terminology: nomenclature of mucosa-associated lymphoid tissue","volume":"1","author":"Brandtzaeg","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0425","first-page":"1","article-title":"Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues","volume":"354","author":"Czerzinsky","year":"2012","journal-title":"Curr Top Microbiol Immun"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0430","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0435","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5699(92)90158-4","article-title":"The role of nasopharyngeal lymphoid tissue","volume":"13","author":"Kuper","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0440","series-title":"Mucosal immunology. 1","first-page":"415","article-title":"Nasal-associated lymphoid tissue","author":"Kraal","year":"2005"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0445","series-title":"Principles of mucosal immunology","first-page":"293","article-title":"The nasopharyngeal and oral immune system","author":"Kiyono","year":"2013"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0450","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery-possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J Contr Release"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0455","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/jps.21493","article-title":"Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems","volume":"98","author":"Sharma","year":"2009","journal-title":"J Pharmaceut Syst"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0460","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1099\/jmm.0.043885-0","article-title":"A novel intranasal mouse model for mucosal colonisation of Streptococcus suis serotype 2","volume":"61","author":"Seitz","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0465","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1586\/14760584.7.8.1257","article-title":"Mucosal vaccination against bacterial respiratory infections","volume":"7","author":"Baumann","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0470","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1165\/rcmb.2004-0207OC","article-title":"Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by normal microbiota","volume":"31","author":"Henriksson","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0475","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/mi.2013.99","article-title":"Harnessing local and systemic immunity for vaccines against tuberculosis","volume":"7","author":"Beverly","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0480","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2010.55","article-title":"Topical immunization strategies","volume":"3","author":"Czerkinsky","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0485","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.it.2008.07.008","article-title":"Immunological commonalities and distinctions between airway and digestive immunity","volume":"29","author":"Kunisawa","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0490","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/317926","article-title":"Immunization against influenza: comparison of various topical and parental regimens containing inactivate and\/or live attenuate vaccines in healthy adults","volume":"183","author":"Keitel","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0495","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"Rose","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0500","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1465-9921-8-57","article-title":"Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I\/II study","volume":"8","author":"Baumann","year":"2007","journal-title":"Respir Res"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0505","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1128\/IAI.72.11.6546-6553.2004","article-title":"Enhanced immogenicity in the murine airway mucosa with an attenuated salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa","volume":"72","author":"Arnold","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0510","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0264-410X(00)00550-8","article-title":"Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers","volume":"19","author":"Larbig","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0515","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0928-8244(03)00094-4","article-title":"Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. mucosal booster schedule","volume":"37","author":"G\u00f6cke","year":"2003","journal-title":"TEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0520","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.vaccine.2009.10.080","article-title":"Systemic, nasal and live vaccines against Pseudomonas aeruginosa: clinical trial of immunogenicity in lower airways of human volunteers","volume":"28","author":"Bumann","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/17425247.3.2.247","article-title":"Intranasal delivery of vaccines against HIV","volume":"3","author":"Vajdy","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0530","first-page":"217","article-title":"Streptococcus pneumonia: epidemiology and risk factors, evolution of antimicrobial resistance, and the impact of vaccines","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0535","series-title":"Principles of mucosal immunology","first-page":"293","article-title":"The nasopharyngeal and oral immune system","author":"Fujihashi","year":"2013"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0540","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jam.2006.19.92","article-title":"Nasal clearance in health and disease","volume":"19","author":"Illum","year":"2006","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0545","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0550","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery-possibilities problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0555","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/cne.23694","article-title":"Olfactory ensheathing cells are the main phagocytic cells that remove axon debris during early development of the olfactory system","volume":"532","author":"Nazareth","year":"2015","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0560","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/glia.20899","article-title":"Olfactory ensheathing cells: nitric oxide production and innate immunity","volume":"57","author":"Harris","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0565","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2010.08.029","article-title":"Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair","volume":"229","author":"Wewetzer","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0570","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4161\/viru.2.4.16138","article-title":"Host strategies against virus entry via the olfactory system","volume":"2","author":"Kalinke","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0575","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00418-011-0796-0","article-title":"Cell surfaxe expression of 27C7 neonatal rat olfactory ensheathing cells in situ and in vitro is independent of axonal contact","volume":"135","author":"Brandes","year":"2011","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0580","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00229081","article-title":"Nasal lymphoid tissue in the rat","volume":"255","author":"Spit","year":"1989","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0585","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/01926230600867735","article-title":"Histopathology of mucosa-associated lymphoid tissue","volume":"34","author":"Kuper","year":"2006","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0590","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00218901","article-title":"An immunohistochemical study on the postnatal development of rat nasal-associated lymphoid tissue (NALT)","volume":"256","author":"Hameleers","year":"1989","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0595","first-page":"69","article-title":"The development and structure of mouse nasal-associated lymphoid tissue: an immune- and enzyme-histochemical study","volume":"5","author":"van der Ven","year":"1993","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0600","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.etp.2009.09.004","article-title":"Woutersen RA. Hyperplasia of the lymphoepithelium of NALT in rats but not in mice after 28-day exposure to 15ppm formaldehyde vapor","volume":"63","author":"Kuper","year":"2011","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0605","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.imlet.2010.10.001","article-title":"Effects of restraint stress on NALT structure and nasal IgA levels","volume":"135","author":"Oros-Pantoja","year":"2011","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0610","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.171.5.2532","article-title":"Membranous cells in nose-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus","volume":"171","author":"Park","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0615","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/eji.200939422","article-title":"Antigen dependent rescue of nose-assoviated lymphoid tissue (NALT) development independent of LT\u00dfR and CXCR5 signaling","volume":"39","author":"Krege","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0620","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/1521-4141(200211)32:11<3029::AID-IMMU3029>3.0.CO;2-9","article-title":"Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues","volume":"32","author":"Csencsits","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0625","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1084\/jem.20101786","article-title":"Essential role of peripheral node addressin in lymphocyte homing nasal-associated lymphoid tissues and allergic immune responses","volume":"208","author":"Ohmichi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0630","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.156.4.97-03017","article-title":"Comparison of murine nasal-associated lymphoid tissue and Peyer's patches","volume":"156","author":"Heritage","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0635","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(96)00243-8","article-title":"Isolation and characterization of mouse nasal-associated lymphoid tissue","volume":"202","author":"Asanuma","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0640","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0264-410X(98)00048-6","article-title":"IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccination by intranasal, intravenous and\/or subcutaneous administration","volume":"16","author":"Asanuma","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0645","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0650","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.4049\/jimmunol.172.10.6259","article-title":"IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut","volume":"172","author":"Shikina","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0655","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/CVI.00477-10","article-title":"Nasal immunity to Staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue","volume":"18","author":"Fernandez","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0660","first-page":"3960","article-title":"Examining the role of nasopharyngeal-associated lymph reticular tissue (NALT) in mouse responses to vaccines","volume":"66","author":"Cisney","year":"2012","journal-title":"J Visual Exper"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0665","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000071154","article-title":"Anatomy of the nasal cavity in the chinchilla","volume":"174","author":"Jurcisek","year":"2003","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0670","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mi.2011.6","article-title":"Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to non-typeable Haemophilus influenzae","volume":"4","author":"Novotny","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0675","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/0192623311409594","article-title":"Evaluation of the rabbit nasal cavity in inhalation studies and a comparison with other common laboratory species and man","volume":"39","author":"Pereira","year":"2011","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0680","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1051\/vetres:2006001","article-title":"MALT structure and function in farm animals","volume":"37","author":"Liebler-Tenorio","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/472460","article-title":"The tonsils revisited: review of the anatomical localization and histological characteristics of the tonsils of domestic and laboratory animals","author":"Casteleyn","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0690","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2003.02311.x","article-title":"Nasal-associated lymphoid tissue (NALT): frequency and localization in young children","volume":"134","author":"Debertin","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0695","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s004289900177","article-title":"Evidence of M cells as portal of entry for antigens in the nasopharyngeal lymphoid tissue of humans","volume":"436","author":"Fujimura","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0700","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.vaccine.2008.01.027","article-title":"Intranasal vaccination of infant mice induces protection immunity in the absence of nasal-association lymphoid tissue","volume":"26","author":"Sabirov","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0705","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.175.5.3186","article-title":"Upper respiratory tract resistance to influenza infection is not prevented by absence of either nasal-associated lymphoid tissue or cervical lymph nodes","volume":"175","author":"Wiley","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0710","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.vaccine.2010.05.075","article-title":"Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine","volume":"28","author":"Ronan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0715","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.4049\/jimmunol.0903794","article-title":"The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens","volume":"186","author":"Kim","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0720","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.173.6.1345","article-title":"Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways","volume":"173","author":"Schon-Hegrad","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0725","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1165\/rcmb.2002-0230OC","article-title":"Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes","volume":"30","author":"Jahnsen","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0730","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to Antrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0735","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.vaccine.2006.03.007","article-title":"Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa","volume":"24","author":"Zuercher","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0740","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2010.08.006","article-title":"Adjuvant effect of Bacillus firmus on the expression of cytokines and toll-like receptors in mouse nasopharynx-associated lymphoid tissue (NALT) after intranasal immunization with inactivated influenza virus type A","volume":"134","author":"Zanvit","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0745","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.vaccine.2010.05.005","article-title":"Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces non-typeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx","volume":"28","author":"Noda","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0750","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2010.01.027","article-title":"Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine","volume":"144","author":"Hagenaars","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0755","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/S0264-410X(99)00442-9","article-title":"Inactivated meningococci and pertussis bacteria are immunogenetic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine","volume":"18","author":"Berstad","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0760","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2011.12.046","article-title":"Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses","volume":"418","author":"Fukuyama","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0765","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jaci.2007.08.046","article-title":"Epithelium at the interface of innate and adaptive immune responses","volume":"120","author":"Schleimer","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00018","article-title":"The genetic regulation of infant immune responses to vaccination","volume":"6","author":"Newport","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0775","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.vaccine.2011.10.093","article-title":"A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging","volume":"30","author":"Asanuma","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.022_bib0780","series-title":"Sobotta atlas of anatomy. 3","author":"Putz","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T07:52:03Z","timestamp":1566978723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":78,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15009664"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)\u2014Structure, function and species differences","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}